1. Home
  2. TCBK vs NNNN Comparison

TCBK vs NNNN Comparison

Compare TCBK & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriCo Bancshares

TCBK

TriCo Bancshares

HOLD

Current Price

$47.11

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$22.77

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCBK
NNNN
Founded
1975
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
TCBK
NNNN
Price
$47.11
$22.77
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$53.80
N/A
AVG Volume (30 Days)
140.5K
39.6K
Earning Date
04-23-2026
01-01-0001
Dividend Yield
2.98%
N/A
EPS Growth
6.94
N/A
EPS
3.70
N/A
Revenue
$53,445,000.00
N/A
Revenue This Year
$11.70
N/A
Revenue Next Year
$4.47
N/A
P/E Ratio
$13.04
$446.57
Revenue Growth
4.12
N/A
52 Week Low
$35.20
$5.91
52 Week High
$53.18
$55.65

Technical Indicators

Market Signals
Indicator
TCBK
NNNN
Relative Strength Index (RSI) 36.65 44.41
Support Level $46.76 $22.08
Resistance Level $51.11 $31.44
Average True Range (ATR) 1.44 2.46
MACD -0.32 -0.09
Stochastic Oscillator 18.47 16.81

Price Performance

Historical Comparison
TCBK
NNNN

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: